| IV-58 Tim Preijers Dosing of convalescent plasma and hyperimmune anti-SARS-CoV-2 immunoglobulins: a phase I/II dose finding study Thursday 15:25-16:55 |
| IV-58 Tim Preijers Dosing of convalescent plasma and hyperimmune anti-SARS-CoV-2 immunoglobulins: a phase I/II dose finding study Thursday 15:25-16:55 |